Patients | Age (years old) | Gender | Tumor | Bevacizumab (cycles) | Lesion | Location | Radiotherapy | Bev from RT (month) | Response rate ( %) | Radiological assessment |
---|---|---|---|---|---|---|---|---|---|---|
Case 2 | 52 | M | anaplastic | 3 | Necrosis 1 | occipital | SRS 14Gy/ SRS 14Gy/ SRT 25.5Gy/BNCT | 13 | −100 | Response |
Case 3 | 76 | F | atypical | 6 | Necrosis 2 | parasagittal | SRT 24Gy/ BNCT | 8 | −65 | Response |
Case 5 | 69 | F | grade I | 3 | Necrosis 3 | parasagittal | SRS/ SRS | 13 | −76 | Response |
Case 6 | 46 | F | anaplastic | 6 | Necrosis 4 | frontal | EBRT 60Gy/ BNCT/BNCT | 4 | −51 | Response |